Multiple Sclerosis
Research into Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) is growing, with studies focusing on safety, feasibility, and potential neurological effects. Investigations explore whether MSCs may support repair processes in the central nervous system and modulate immune responses.
Multiple Sclerosis is a chronic autoimmune disease in which the immune system attacks the protective myelin sheath around nerves. This leads to a wide range of symptoms, including fatigue, vision problems, muscle weakness, and difficulties with coordination. Current treatments may slow progression but do not reverse existing damage.
MSC studies in MS remain exploratory, but early findings suggest possible roles in neuroprotection, inflammation control, and repair support. Continued research is essential for clarifying the potential of MSC-based approaches within the broader field of neurodegenerative disease treatment.
Clinical Trials